Preoperative Surgical Fear and Related Factors of Patients Undergoing Brain Tumor Surgery


SÜRME Y., Çimen Ö.

Journal of Perianesthesia Nursing, cilt.37, sa.6, ss.934-938, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 6
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.jopan.2022.04.006
  • Dergi Adı: Journal of Perianesthesia Nursing
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, CINAHL, EMBASE, MEDLINE, DIALNET
  • Sayfa Sayıları: ss.934-938
  • Anahtar Kelimeler: Brain tumor, Surgery, Fear, Preoperative
  • Erciyes Üniversitesi Adresli: Evet

Özet

© 2022 American Society of PeriAnesthesia NursesPurpose: Patients with brain tumors may experience preoperative fear due to various reasons such as obscurity, pain, and loss of function. This study was carried out to reveal the pre-operative fear levels of patients undergoing brain tumor surgery. Design: This descriptive and cross-sectional study was completed with 144 patients. Methods: Data were obtained using patient identification forms and the Surgical Fear Questionnaire (SFQ). Descriptive statistics, independent t test, one-way Anova, Pearson correlation, and multiple regression analysis were used. Findings: The results revealed that the duration of preoperative hospital stay was 3.05 ± 2.26 days, the mean age of the patients was 51.44 ± 13.76 years, and more than half (54.1%) were male. The SFQ total and subscale mean scores of patients who are not working were higher (P <.05). The mean SFQ total and subscale mean scores of those aged 53 and over were lower. (P <.05). Duration of preoperative hospital stay, age, and female gender were statistically significant predictors of SFQ. Duration of preoperative hospital stay was responsible for 62.3% of the change in the SFQ, female gender was responsible for 17.6%, and age was responsible for 20.4%. Conclusion: Understanding the risk factors for preoperative fear can help identify patients at risk. Factors that cause fear should be investigated and information deficiencies that increase the level of fear should be eliminated. It is recommended to use pharmacological and nonpharmacological methods in managing the fear of risk groups.